Clinical Trial

Efficacy and Safety of Microtransplantation for Advanced and Relapsed Solid Tumors

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
In this study, microtransplantation (MST) will be administrated to patients diagnosed with advanced / relapsed solid tumors to assess the therapeutic efficacy and safety of conventional chemotherapy in combination with MST for the treatment of advanced/relapsed solid tumors.
Trial Details
NCT Number NCT07356856
Lead Sponsor The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Conditions Advanced and Relapsed Solid Tumors
Enrollment 10 participants
Start Date 2026-01-15
Primary Completion 2028-01-16 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-21